February 18, 2026
India – France Relations
During the official visit of French President Emmanuel Macron to India (February 17–19, 2026), Prime Minister Narendra Modi and President Macron announced a historic upgrade of their relationship to a “Special Global Strategic Partnership.”
A total of 21 major outcomes were announced, focusing on defense, innovation, and health. Here are the key points:
- Defense & Aerospace: “Aatmanirbhar Bharat” Milestones
- H125 Helicopter Assembly Line: Inaugurated the first private-sector helicopter Final Assembly Line in Vemagal, Karnataka (a Tata-Airbus partnership). It will produce the world’s only helicopter capable of flying at Mt. Everest altitudes.
- HAMMER Missile Production: A new Joint Venture between Bharat Electronics Limited (BEL) and Safran was signed to manufacture HAMMER missiles in India.
- Aero-Engine MRO Facilities: Announced the establishment of Maintenance, Repair, and Overhaul (MRO) facilities for LEAP engines (commercial) and M-88 engines (for Rafale jets) in India.
- Rafale Expansion: Discussions advanced for the acquisition of 114 more Rafale jets, with a push for 50% indigenous content.
- Technology & Innovation:
- India-France Year of Innovation (2026): Formally launched to boost collaboration between startups, students, and researchers.
- Indo-French Centre for AI in Health: Launched at AIIMS, New Delhi, to leverage AI for medical advancements.
- Digital Science & Technology: Established a new joint center for Digital Sciences and a National Centre of Excellence for Skilling in Aeronautics.
- Strategic & Economic Pacts:
- Annual Foreign Ministers Dialogue: A new institutional mechanism to review the “Horizon 2047 Roadmap” every year.
- Critical Minerals: Signed a Joint Declaration of Intent for cooperation in the supply chains of critical minerals and metals.
- Taxation & Economy: Amended the Double Tax Avoidance Agreement (DTAA) to simplify cross-border investments.
Summary Table of Key Agreements:
| Sector |
Key Outcome |
Partnering Entities |
| Defense |
H125 Helicopter Manufacturing |
Tata & Airbus |
| Missiles |
HAMMER Missile Production |
BEL & Safran |
| Health |
AI in Health Centre |
AIIMS (Delhi) & France |
| Innovation |
2026 Year of Innovation |
India-France Govt |
| Diplomacy |
Special Global Strategic Partnership |
Elevated Status |
India-France Year of Innovation (2026):
This year-long initiative is designed as a “shared commitment” to unite the world’s third-largest startup ecosystem (India) with one of Europe’s leading innovation hubs (France).
- India Innovates 2026: A flagship event will be held in France in June 2026, where top Indian tech startups will showcase solutions for global challenges in health, climate, and security.
- Indo-French Innovation Network: A digital platform built by Capgemini and operated by the Indo-French Chamber of Commerce and Industry (IFCCI) to provide a “single-entry” point for startups and researchers to collaborate.
- Strategic Focus: The initiative emphasizes “Technological Sovereignty,” ensuring both nations remain leaders in AI, semiconductors, clean energy, and quantum computing rather than just consumers.
Indo-French Centre for AI in Health
Launched at AIIMS, New Delhi, this center represents a shift toward “Human-Centric AI.” It combines France’s advanced neuro-imaging expertise with India’s massive healthcare scale.
- Brain Health Focus: The primary goal is the early detection of neurological conditions like Alzheimer’s and Parkinson’s disease using machine learning-enabled MRI analysis.
- Key Partners: The collaboration involves:
-
- AIIMS New Delhi & IIT Delhi (for algorithm development).
- Sorbonne University & the Paris Brain Institute (for neuro-imaging expertise).
- Diagnostic Impact: By using AI to support imaging, the center aims to improve diagnostic accuracy and bridge the gap for patients in areas where access to specialists is limited.
Comparison of Key Features:
| Feature |
Year of Innovation 2026 |
Indo-French Centre for AI in Health |
| Primary Hub |
Mumbai / Paris |
AIIMS, New Delhi |
| Main Objective |
Startup & R&D Scaling |
Early Disease Detection & AI Diagnostics |
| Target Audience |
Startups, MSMEs, Researchers |
Clinicians, Data Scientists, Patients |
| Strategic Goal |
Global Tech Leadership |
Accessible Healthcare Innovation |